125 related articles for article (PubMed ID: 6960545)
1. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
[TBL] [Abstract][Full Text] [Related]
2. Platelet function in patients with high platelet counts.
Ginsburg AD
Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
[TBL] [Abstract][Full Text] [Related]
3. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
4. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
5. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Brodsky I; Kahn SB; Ross EM; Petkov G
Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
[No Abstract] [Full Text] [Related]
6. Clinical significance of beta-thromboglobulin in patients with high platelet count.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
[TBL] [Abstract][Full Text] [Related]
7. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
8. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
Smith IL; Martin TJ
Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
10. Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion.
Löfvenberg E; Nilsson TK
Eur J Haematol; 1989 Nov; 43(5):435-40. PubMed ID: 2612617
[TBL] [Abstract][Full Text] [Related]
11. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
[TBL] [Abstract][Full Text] [Related]
12. Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
Cortellazzo S; Viero P; Buczko W; Barbui T; de Gaetano G
Scand J Haematol; 1985 Feb; 34(2):146-51. PubMed ID: 3856312
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
Barbui T; Battista R; Dini E
Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
[No Abstract] [Full Text] [Related]
14. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
15. Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alpha.
Sinzinger H; Linkesch W; Ludwig H; Gisslinger H; O'Grady J; Peskar BA
Prostaglandins; 1990 Oct; 40(4):351-60. PubMed ID: 2126385
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
Balduini CL; Bertolino G; Noris P; Piletta GC
Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
[TBL] [Abstract][Full Text] [Related]
17. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
18. Platelet function abnormalities in the myeloproliferative disorders.
Adams T; Schutz L; Goldberg L
Scand J Haematol; 1974; 13(3):215-24. PubMed ID: 4533155
[No Abstract] [Full Text] [Related]
19. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
Takayama H; Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
Prostaglandins Leukot Med; 1983 Nov; 12(3):261-72. PubMed ID: 6318227
[TBL] [Abstract][Full Text] [Related]
20. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
